Research Paper Volume 13, Issue 5 pp 7361—7381

Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system

mPS system can precisely stratify prognosis of ccRCC patients and is applicable to T1 and T2 ccRCC subsets. (A) Kaplan-Meier curves of OS according to mPS for the TCGA cohort; (B) Kaplan-Meier curves of OS according to mPS for the ICGC cohort; (C) Kaplan-Meier curves according to mPS for OS of patients at clinical T1 and T2 stage in the TCGA cohort; (D) Kaplan-Meier curves according to mPS for OS of patients at clinical T1 and T2 stage in the ICGC cohort.

Figure 4. mPS system can precisely stratify prognosis of ccRCC patients and is applicable to T1 and T2 ccRCC subsets. (A) Kaplan-Meier curves of OS according to mPS for the TCGA cohort; (B) Kaplan-Meier curves of OS according to mPS for the ICGC cohort; (C) Kaplan-Meier curves according to mPS for OS of patients at clinical T1 and T2 stage in the TCGA cohort; (D) Kaplan-Meier curves according to mPS for OS of patients at clinical T1 and T2 stage in the ICGC cohort.